Sheel Biotech Limited (NSE:SHEEL)
India · Delayed Price · Currency is INR 61.00
-1.00 (-1.61%)
At close: Sep 11, 2026
Sheel Biotech Revenue
In the fiscal year ending March 31, 2026, Sheel Biotech had annual revenue of 1.10B INR with 8.13% growth. Sheel Biotech had revenue of 881.73M in the half year ending March 31, 2026.
Revenue
1.10B
Revenue Growth
+8.13%
P/S Ratio
1.13
Revenue / Employee
7.54M
Employees
n/a
Market Cap
1.24B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.10B | 82.70M | 8.13% |
| Mar 31, 2025 | 1.02B | 94.70M | 10.26% |
| Mar 31, 2024 | 922.82M | 121.67M | 15.19% |
| Mar 31, 2023 | 801.16M | 93.80M | 13.26% |
| Mar 31, 2022 | 707.36M | 77.08M | 12.23% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| JK Agri Genetics | 1.50B |
| Mangalam Seeds | 1.25B |
| Indo Us Bio-Tech | 1.13B |
| Tierra Agrotech | 1.12B |
| Saptarishi Agro Industries | 937.03M |
| Stanbik Agro | 858.95M |
| Nagarjuna Agri-Tech | 832.38M |
| Unisem Agritech | 810.34M |